3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Colorectal Neoplasms
13
Carcinoma, Hepatocellular
7
Neoplasms
3
Liver Neoplasms
2
Glioblastoma
2
Gastrointestinal Stromal Tumors
2
Colonic Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Recurrence
1
Rectal Neoplasms
1
Piebaldism
1
Patient Compliance
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Microsatellite Stable Metastatic Colorectal Cancer
1
Meningioma
1
Melanoma
1
MCRC
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Liver Metastases
1
Leiomyosarcoma
1
Interventions
pembrolizumab
3
Doxorubicin
3
Standard of Care
2
Ifosfamide
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
spartalizumab
1
selinexor
1
sarilumab
1
regorafenib
1
pexidartinib
1
pertuzumab
1
pazopanib
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
durvalumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Watchful Waiting
1
Trastuzumab
1
STA 9090
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Hemangiosarcoma
×
regorafenib
×
Clear all
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled